Therefore, in the context of CCA, inhibiting GPBAR1 expression at least partially inhibits the proliferation and migration of cancer cells, indicating that GPBAR1 may be a potential therapeutic target for CCA treatment. This evidence concerns the gene GPBAR1 and cancer.